Spectroscopy imaging in intraoperative MR suite: tissue characterization and optimization of tumor resection

BackgroundMR spectroscopy (MRS) measurements are common practice in the preoperative diagnostic regimen, but no evidence exists concerning their value in intraoperative MRI (iMRI) setting. We sought to examine the feasibility of intraoperative MRS and to assess the clinical value of the method in optimizing the gliomas resection.MethodsForty-five patients with low- and high-grade gliomas underwent iMRI-assisted surgery, including pre- and intraoperative MRS measurements. During the intraoperative control scan, MRS was performed at the resection margin. Peak areas under the major metabolites (N-acetyl-aspartate: NAA; choline: Cho; and creatine: Cr) resonances were estimated, and their ratios entered in the statistical analysis.ResultsConcerning preoperative MRS imaging, mean Cho/NAA and Cho/Cr ratios in low-grade gliomas were 2.3 and 1.2, respectively. The average Cho/NAA and Cho/Cr ratios in the high-grade gliomas were 3.9 and 2.3, respectively. In 12 out of 20 cases with low-grade gliomas, intraoperative conventional MR imaging showed suspected tumor remnant and MRS diagnosed correctly the tissue signal alterations in 10 out of those 12 cases. MRS could characterize gadolinium-enhancing or non-enhancing tumor remnants in all cases with high-grade tumors. Thus, it could help achieve total tumor resection unless the latter was contraindicated due to increased risk of neurological complications.ConclusionsMR spectroscopy (MRS) in an iMRI setting is feasible, facilitating preoperative glioma staging as well as satisfactory characterization of suspected tumor remnants. Thus, it may be helpful tool for an extended tumor resection.

[1]  Xiaolei Chen,et al.  Dual-room 1.5-T intraoperative magnetic resonance imaging suite with a movable magnet: implementation and preliminary experience , 2011, Neurosurgical Review.

[2]  Sotirios Bisdas,et al.  Intraoperative Visualization of Residual Tumor: The Role of Perfusion-Weighted Imaging in a High-Field Intraoperative Magnetic Resonance Scanner , 2013, Neurosurgery.

[3]  Christopher Nimsky,et al.  Intraoperative visualization of the pyramidal tract by diffusion-tensor-imaging-based fiber tracking , 2006, NeuroImage.

[4]  T. Tominaga,et al.  Differential diagnosis between radiation necrosis and glioma progression using sequential proton magnetic resonance spectroscopy and methionine positron emission tomography. , 2009, Neurologia medico-chirurgica.

[5]  Christopher Nimsky,et al.  Intraoperative functional MRI: Implementation and preliminary experience , 2005, NeuroImage.

[6]  Edward E Graves,et al.  Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy. , 2002, International journal of radiation oncology, biology, physics.

[7]  Elke Hattingen,et al.  Prognostic value of choline and creatine in WHO grade II gliomas , 2008, Neuroradiology.

[8]  Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. , 1997 .

[9]  Damien Galanaud,et al.  Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma. , 2003, Journal of neurosurgery.

[10]  Tommaso Scarabino,et al.  Proton MR spectroscopy of cerebral gliomas at 3 T: spatial heterogeneity, and tumour grade and extent , 2008, European Radiology.

[11]  Susan M. Chang,et al.  Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM. , 2010, Neuro-oncology.

[12]  Bernd J Pichler,et al.  Multimodal elucidation of choline metabolism in a murine glioma model using magnetic resonance spectroscopy and 11C-choline positron emission tomography. , 2013, Cancer research.

[13]  Elke Hattingen,et al.  MR spectroscopy differentiation between high and low grade astrocytomas: a comparison between paediatric and adult tumours. , 2011, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[14]  G Evren Keles.  Intracranial neuronavigation with intraoperative magnetic resonance imaging , 2004, Current opinion in neurology.

[15]  A. Dinçer,et al.  First intraoperative, shared-resource, ultrahigh-field 3-Tesla magnetic resonance imaging system and its application in low-grade glioma resection. , 2010, Journal of neurosurgery.

[16]  Theodoros N. Arvanitis,et al.  Functional imaging in adult and paediatric brain tumours , 2012, Nature Reviews Clinical Oncology.

[17]  J A Frank,et al.  Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. , 1992, Radiology.

[18]  Michael Forsting,et al.  A novel passive functional MRI paradigm for preoperative identification of the somatosensory cortex , 2004, Neurosurgical Review.

[19]  T Nakada,et al.  Localized proton spectroscopy of focal brain pathology in humans: Significant effects of edema on spin–spin relaxation time , 1994, Magnetic resonance in medicine.

[20]  Glyn Johnson,et al.  Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. , 2003, AJNR. American journal of neuroradiology.

[21]  G. Rao,et al.  IMPACT OF INTRAOPERATIVE HIGH‐FIELD MAGNETIC RESONANCE IMAGING GUIDANCE ON GLIOMA SURGERY: A PROSPECTIVE VOLUMETRIC ANALYSIS , 2009, Neurosurgery.

[22]  Sabine Van Huffel,et al.  Multiproject–multicenter evaluation of automatic brain tumor classification by magnetic resonance spectroscopy , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.

[23]  J. O'Callaghan,et al.  Astrogliosis in CNS Pathologies: Is There A Role for Microglia? , 2010, Molecular Neurobiology.

[24]  R. Henry,et al.  Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas , 2006, NMR in biomedicine.

[25]  V. Haughton,et al.  Accuracy of single-voxel proton MR spectroscopy in distinguishing neoplastic from nonneoplastic brain lesions. , 1997, AJNR. American journal of neuroradiology.

[26]  Y. Kinoshita,et al.  Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy , 1997, NMR in biomedicine.

[27]  Keles Ge,et al.  Intracranial neuronavigation with intraoperative magnetic resonance imaging , 2004 .

[28]  Christopher Nimsky,et al.  Intraoperative visualization for resection of gliomas: the role of functional neuronavigation and intraoperative 1.5 T MRI , 2006, Neurological research.

[29]  H. Lanfermann,et al.  DIAGNOSTIC VALUE OF PROTON MAGNETIC RESONANCE SPECTROSCOPY IN THE NONINVASIVE GRADING OF SOLID GLIOMAS: COMPARISON OF MAXIMUM AND MEAN CHOLINE VALUES , 2009, Neurosurgery.

[30]  H. Minn,et al.  Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS , 2003, Journal of Neuro-Oncology.

[31]  Ying Lu,et al.  Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients , 2002, Journal of magnetic resonance imaging : JMRI.

[32]  Dong Wang,et al.  Intraoperative High-Field Magnetic Resonance Imaging Combined With Fiber Tract Neuronavigation-Guided Resection of Cerebral Lesions Involving Optic Radiation , 2011, Neurosurgery.

[33]  Christopher Nimsky,et al.  Quantification of Glioma Removal by Intraoperative High-Field Magnetic Resonance Imaging: An Update , 2011, Neurosurgery.

[34]  C. Nimsky,et al.  Changes in fiber integrity, diffusivity, and metabolism of the pyramidal tract adjacent to gliomas: a quantitative diffusion tensor fiber tracking and MR spectroscopic imaging study. , 2007, AJNR. American journal of neuroradiology.

[35]  R. Kreis.  Issues of spectral quality in clinical 1H‐magnetic resonance spectroscopy and a gallery of artifacts , 2004, NMR in biomedicine.